Genes related to N6-methyladenosine in the diagnosis and prognosis of idiopathic pulmonary fibrosis

Genes related to N6-methyladenosine in the diagnosis and prognosis of idiopathic pulmonary fibrosis

Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic progressive pulmonary fibrotic disease with unknown etiology and poor outcomes. It severely affects the quality of life. In this study, we comprehensively analyzed the expression of N6-methyladenosine (m6A) RNA methylation regulators usi...

Full description

Bibliographic Details
Main Authors:	Jingcheng Zhang, Ying Zhang, Ziyuan Wang, Jiachao Zhao, Zhenyu Li, Keju Wang, Lin Tian, Baojin Yao, Qibiao Wu, Tan Wang, Jing Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Genetics
Subjects:	idiopathic pulmonary fibrosis N6-methyladenosine METTL14 diagnosis prognosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.1102422/full

Similar Items

Emerging Roles of N6-Methyladenosine Modification in Neurodevelopment and Neurodegeneration
by: Liqi Shu, et al.
Published: (2021-10-01)

METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma
by: Zhijin Zhang, et al.
Published: (2023-06-01)

PRMT1 methylates METTL14 to modulate its oncogenic function
by: Jingchao Wang, et al.
Published: (2023-08-01)

N6-methyladenosine-modified lncRNA and mRNA modification profiles in cerebral ischemia-reperfusion injury
by: Le Shao, et al.
Published: (2022-11-01)

N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner
by: You-Qing Miao, et al.
Published: (2022-01-01)

Insights into the Regulatory Role of m<sup>6</sup>A Epitranscriptome in Glioblastoma
by: Silvia Galardi, et al.
Published: (2020-04-01)

Metformin enhances METTL14-Mediated m6A methylation to alleviate NIT-1 cells apoptosis induced by hydrogen peroxide
by: Si-min Zhou, et al.
Published: (2024-01-01)

Dynamics of N6-methyladenosine modification during Alzheimer's disease development
by: Shuai Gao, et al.
Published: (2024-03-01)

Idiopathic pulmonary fibrosis: current diagnosis and treatment
by: Alexandre Franco Amaral, et al.
Published: (2023-08-01)

Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma
by: Yi Wang, et al.
Published: (2021-01-01)

Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell–mediated antitumor activity
by: Hao Zheng, et al.
Published: (2022-12-01)

Decreased Expression of Programmed Death Ligand-L1 by Seven in Absentia Homolog 2 in Cholangiocarcinoma Enhances T-Cell–Mediated Antitumor Activity
by: Hao Zheng, et al.
Published: (2022-01-01)

Mettl14-mediated m6A modification enhances the function of Foxp3+ regulatory T cells and promotes allograft acceptance
by: Yanzhuo Liu, et al.
Published: (2022-10-01)

Corrigendum: Mettl14-mediated m6A modification enhances the function of Foxp3+ regulatory T cells and promotes allograft acceptance
by: Yanzhuo Liu, et al.
Published: (2022-12-01)

N6-methyladenosine (m6A) writer METTL3 accelerates the apoptosis of vascular endothelial cells in high glucose
by: Zhenjin Li, et al.
Published: (2023-03-01)

N6-methyladenosine modification positively regulate Japanese encephalitis virus replication
by: Min Yao, et al.
Published: (2024-01-01)

The potential role of RNA N6-methyladenosine in primary Sjögren’s syndrome
by: Qiufeng Xiao, et al.
Published: (2022-11-01)

N6-methyladenosine (m6A) in cancer stem cell: From molecular mechanisms to therapeutic implications
by: Liming Wang, et al.
Published: (2023-07-01)

Idiopathic Pulmonary Fibrosis and Telomeres
by: Alba Mulet, et al.
Published: (2022-11-01)

Corrigendum: The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome
by: Qiufeng Xiao, et al.
Published: (2023-07-01)

The identification of metabolism-related subtypes and potential treatments for idiopathic pulmonary fibrosis
by: Changqing Yang, et al.
Published: (2023-05-01)

N6-methyladenosine mediates Nrf2 protein expression involved in PM2.5-induced pulmonary fibrosis
by: Ding Ji, et al.
Published: (2023-04-01)

Isolation, Characterization, and Anti-Idiopathic Pulmonary Fibrosis Activity of a Fucoidan from <i>Costaria costata</i>
by: Sijie Wei, et al.
Published: (2023-05-01)

The Role of Immune Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis
by: Yahan Xu, et al.
Published: (2023-11-01)

Incidence and Clinical Characteristics of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
by: Wei Yan, et al.
Published: (2015-01-01)

The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
by: Paschalis Ntolios, et al.
Published: (2021-04-01)

Solution structure of the RNA recognition domain of METTL3-METTL14 N6-methyladenosine methyltransferase
by: Jinbo Huang, et al.
Published: (2018-03-01)

RNA N6-methyladenosine modification mediates downregulation of NR4A1 to facilitate malignancy of cervical cancer
by: Tao Yu, et al.
Published: (2022-12-01)

Relevance of RNA N6-Methyladenosine Regulators for Pulmonary Fibrosis: Implications for Chronic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
by: Yiyi Zhou, et al.
Published: (2022-07-01)

External validation of the GAP model in Chinese patients with idiopathic pulmonary fibrosis
by: Xinran Zhang, et al.
Published: (2023-09-01)

Clinical course and management of idiopathic pulmonary fibrosis
by: Caitlin Quinn, et al.
Published: (2019-12-01)

Real-world practice of idiopathic pulmonary fibrosis: Results from a 2000–2016 cohort
by: Wang Ying-Tso, et al.
Published: (2023-11-01)

Analysis of the safety and efficacy of different plasma concentrations of pirfenidone in patients with idiopathic pulmonary fibrosis
by: Hui Li, et al.
Published: (2022-11-01)

Idiopathic pulmonary fibrosis - a disorder of alveolar wound repair?
by: Swiss Medical Weekly
Published: (2003-07-01)

Corrigendum: Relevance of RNA N6-methyladenosine regulators for pulmonary fibrosis: Implications for chronic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis
by: Yiyi Zhou, et al.
Published: (2022-10-01)

Aberrant METTL14 gene expression contributes to malignant transformation of benzene-exposed myeloid cells
by: Chao Wu, et al.
Published: (2024-05-01)

Idiopathic pulmonary fibrosis: the turning point is now!
by: Manuela Funke, et al.
Published: (2015-05-01)

Comprehensive analysis of m6A methylomes in idiopathic pulmonary arterial hypertension
by: Ting Huang, et al.
Published: (2023-12-01)

Cellular and Molecular Mechanisms in Idiopathic Pulmonary Fibrosis
by: Yihang Zhang, et al.
Published: (2023-01-01)

Immunomodulatory effects of exosomes from different resources on idiopathic pulmonary fibrosis
by: Wu Jiamin, Zhang Wei, Zhang Xing, Chen Qi
Published: (2022-05-01)